The Fortier Comparative Orthopedics and Regenerative Medicine Research Laboratory is a leader in advancing our knowledge of the pathogenesis, diagnosis, treatment, and prevention of musculoskeletal disease and injury in both humans and animals. Our laboratory investigates the underlying cellular and molecular mechanisms involved in the development of musculoskeletal pathologies with the ultimate goal of identifying novel molecular targets for its treatment or prevention.
Under the directorship of Dr. Lisa Fortier, the lab group has authored multiple publications over the last decade, participated in conferences and research society meetings all over the country, and trained numerous graduate students, clinical residents, visiting fellows, and veterinary students. By evaluating and treating orthopedic disease with innovative regenerative therapies and working in collaboration with medical doctors, clinicians, engineers, and scientists we optimize our approach for evaluating and treating musculoskeletal diseases.
Current projects include:
- Immunogenic properties of mesenchymal stem cells (MSCs)
- Investigating early events in post-traumatic osteoarthritis
- Optimal leukocyte and platelet concentrations within platelet-rich plasma
- Tendinopathy and tendonitis
- Meniscus replacement
- Cartilage defect repair
- Comparing biologics (BMAC, PRP, Stem Cells)